Dr Reddy’s Laboratories to buy Wockhardt’s domestic business, Baddi plantIllustrative image – not actual.
Dr Reddy’s Laboratories (DRL) will buy Wockhardt’s domestic branded business and manufacturing plant at Baddi in Himachal Pradesh for Rs 1,850 crore.

The transaction, expected to be completed by May 2020, comprises 62 products under the domestic branded business and related assets and liabilities. The sale proceeds will also go into strengthening the balance sheet of the company.

The sale of business portfolio is in line with the company's strategic plan to shift from acute therapeutic areas to more chronic business like anti-diabetes, central nervous system, etc and also to its niche antibiotic portfolio of new chemical entities.

After the deal, Wockhardt will continue to run international operations in UK, USA, Ireland and other locations through its step-down subsidiaries. A significant part of the domestic branded business constituting chronic and speciality portfolios will continue to be run by Wockhardt.

← All latest storiesBack to top →